Yupeng He Kenji Sakuma Taro Kishi Yuanying Li Masaaki Matsunaga Shinichi Tanihara Nakao Iwata Atsuhiko Ota
Journal of Clinical Medicine 13(10) 2970-2970 2024年5月
Background and Objective: Excellent generalizability is the precondition for the widespread practical implementation of machine learning models. In our previous study, we developed the schizophrenia classification model (SZ classifier) to identify...
Aim: This systematic review and frequentist network meta-analysis used random-effects models is conducted to determine whether there are differences in the efficacy, acceptability, tolerability, and safety profiles of brexpiprazole (BRE) and aripi...
Taro Kishi Kenji Sakuma Masakazu Hatano Takenori Okumura Masaki Kato Hajime Baba Nakao Iwata
Neuropsychopharmacology reports 2024年2月
AIM: To update the major depressive disorder (MDD) treatment guidelines of the Japanese Society of Mood Disorders, we conducted a systematic review and pairwise meta-analysis of double-blind, randomized, placebo-controlled trials of available anti...
Yupeng He Masaaki Matsunaga Yuanying Li Taro Kishi Shinichi Tanihara Nakao Iwata Takahiro Tabuchi Atsuhiko Ota
JMIR Formative Research 7 e50193-e50193 2023年11月
Background
In Japan, challenges were reported in accurately estimating the prevalence of schizophrenia among the general population. Retrieving previous studies, we investigated that patients with schizophrenia were more likely to experience poo...
Background. A meta-analysis of the serotonin(1A) (5-HT1A) receptor partial agonist of the azapirone class as an anxiolytic drug for the treatment of major depressive disorder (MDD) has not previously been reported.
Method. We carried out a systema...
お知らせ・マニュアル
医学部